Dr. Luke Nordquist is a MSKCC-trained, practicing Medical Oncologist. His career passions are Cancer Patients and the survival of the Community Cancer Centers. In 2010 Dr. Luke Nordquist founded the Urology Cancer Center & GU Research Network (GURN), based in Omaha, NE dedicated to the Treatment and Research of Urologic Cancers. This research program rapidly gained global recognition and several commendations in the drug development world for its innovative concepts & software, rapid study start-up, standardized processes and efficiencies leading to exception accrual numbers, and prompt accurate data. GURN has been recruited for several phase I, first-in-human trials and requested to partner on trials with some of the most reputable academic institutions.
In 2017, at the request of several Community Cancer Centers that wished to replicate such a research program for their centers, Dr. Nordquist expanded his team and using GURN's experience as the think-tank, formed Precision Cancer Research now rebranded as XCancer®. Through strong relations, XCancer® brings together its expanding network of highly selective community cancer centers with the XCancer® team as their research backbone and investigational drug pipelines from the most innovative pharmaceuticals sponsors and CROs.
In 2021, Dr. Nordquist saw the need to not only connect patients to treatments but also to involve their support systems. That's when the XCancer® Store was created. The XCancer® Store gives family members, friends, and neighbors a chance to contribute to the innovative research happening in their own backyards.
